Xinkui Liu
Overview
Explore the profile of Xinkui Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
813
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang L, Wang J, Dong X, Dove A, Sakakibara S, Liu X, et al.
J Am Med Dir Assoc
. 2025 Jan;
26(3):105465.
PMID: 39828242
Objectives: We aimed to examine changes in the incidence of injurious falls before, during, and after stroke, and to identify risk factors of injurious falls before and after stroke diagnosis....
2.
Zhang Z, Liu X, Chu C, Zhang Y, Li W, Yu X, et al.
Cell Death Dis
. 2024 Oct;
15(10):735.
PMID: 39384743
High-grade serous ovarian carcinoma (HGSOC) is one of the most lethal gynecological cancer. Genetic studies have revealed gene copy number alterations (CNAs) frequently occurred in HGSOC pathogenesis, however the function...
3.
Zhai Y, Zhang F, Zhou J, Qiao C, Jin Z, Zhang J, et al.
Chin Med
. 2024 Sep;
19(1):129.
PMID: 39289763
Background: Combining antitumor proprietary Chinese medicine (pCm) with radiotherapy and chemotherapy can effectively improve tumor cure rates and enhance patients' quality of life. Gastric cancer (GC) severely endangers public health....
4.
Li J, Guo S, Tan Y, Zhang J, Wu Z, Stalin A, et al.
Medicine (Baltimore)
. 2023 Sep;
102(34):e34866.
PMID: 37653800
Background: Coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, leading to a pandemic. In China, Xiyanping injection (XYP) has been recommended as a drug for COVID-19 treatment in the Guideline...
5.
Lu S, Liu X, Wu C, Zhang J, Stalin A, Huang Z, et al.
Medicine (Baltimore)
. 2023 Jul;
102(29):e33990.
PMID: 37478241
Hepatocellular carcinoma (HCC) is one of the most malignant tumors with a poor prognosis. The long non-coding RNA (lncRNA) has been found to have great potential as a prognostic biomarker...
6.
Guo S, Liu X, Zhang J, Huang Z, Ye P, Shi J, et al.
Comput Biol Med
. 2023 Jun;
161:107066.
PMID: 37263064
Background: Triple negative breast cancer (TNBC) is an aggressive and fatal malignancy. The current success of tumor immunotherapy has focused attention on intermediate T-cell subsets and the tumor microenvironment, which...
7.
Zhai Y, Liu X, Huang Z, Zhang J, Stalin A, Tan Y, et al.
Sci Rep
. 2023 Jan;
13(1):1373.
PMID: 36697459
Stomach adenocarcinoma (STAD) is a type of cancer which often at itsadvanced stage apon diagnosis and mortality in clinical practice. Several factors influencethe prognosis of STAD, including the expression and...
8.
Zhang J, Liu X, Huang Z, Wu C, Zhang F, Han A, et al.
Comput Biol Med
. 2022 Dec;
152:106460.
PMID: 36565482
Background: T cells are present in all stages of tumor formation and play an important role in the tumor microenvironment. We aimed to explore the expression profile of T cell...
9.
Li C, Liu X, Huang Z, Zhai Y, Li H, Wu J
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430202
As the most important intestinal mucosal barrier of the main body, the innate immune barrier in intestinal tract plays especially pivotal roles in the overall health conditions of infants and...
10.
Liu X, Bai M, Li H, Ye P, Duan X, Wu C, et al.
Front Immunol
. 2022 Nov;
13:965342.
PMID: 36389835
Background: Due to lack of enough specific targets and the immunosuppressive tumor microenvironment (TME) of triple-negative breast cancer (TNBC), TNBC patients often cannot benefit from a single treatment option. This...